Cited by 26Retinal Diseases and TreatmentsRetinal Imaging and AnalysisRetinal and Macular Surgery

A New Approach to Staging Diabetic Eye Disease

Open access
Channa, Roomasa, Wolf, Risa M., Simo, Rafael, Brigell, Mitchell, Fort, Patrice, Curcio, Christine, Lynch, Stephanie, Verbraak, Frank +11 more·2024·Ophthalmology Science

Abstract

Topic: The goal of this review was to summarize the current level of evidence on biomarkers to quantify diabetic retinal neurodegeneration (DRN) and diabetic macular edema (DME). Clinical relevance: With advances in retinal diagnostics, we have more data on patients with diabetes than ever before. However, the staging system for diabetic retinal disease is still based only on color fundus photographs and we do not have clear guidelines on how to incorporate data from the relatively newer modalities into clinical practice. Methods: In this review, we use a Delphi process with experts to identify the most promising modalities to identify DRN and DME. These included microperimetry, full-field flash electroretinogram, spectral-domain OCT, adaptive optics, and OCT angiography. We then used a previously published method of determining the evidence level to complete detailed evidence grids for each modality. Results: Our results showed that among the modalities evaluated, the level of evidence to quantify DRN and DME was highest for OCT (level 1) and lowest for adaptive optics (level 4). Conclusion: For most of the modalities evaluated, prospective studies are needed to elucidate their role in the management and outcomes of diabetic retinal diseases. Financial Disclosures: Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.xops.2023.100420

Cites

88 of 88 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Initial adoption of AI-aided testing systems is often limited by challenges including lack of trust, resistance to change, training gaps, and uncertainty of the cost-benefit.

    “While AI-aided testing systems hold promise for helping drive down the social and economic burden of DR, initial adoption of new technology is often limited by many challenges including lack of trust, resistance to change, training gaps, and uncertainty of the cost-benefit.9”

    From Autonomous Artificial Intelligence in Diabetic Retinopathy Testing—Lessons Learned on Successful Health System Adoption (2026) · cites this paper as [9]

    The Results section on adaptive optics imaging describes barriers to that modality’s widespread use—time-intensive analysis, limited device availability, and lack of standardization—not barriers to adopting AI-aided testing. Searches for AI adoption, trust, resistance to change, training, and cost-benefit found no passage addressing the claimed challenges; page numbers were unavailable in our copy. (LLM, conf=0.76)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 89 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Channa, R., Wolf, R. M., Simo, R., Brigell, M., Fort, P., Curcio, C., Lynch, S., Verbraak, F., Abramoff, M. D., Abramoff, M. D., Channa, R., Wolf, R. M., Simo, R., Brigell, M., Fort, P., Curcio, C., Lynch, S., Verbraak, F., & Gardner, T. W.
Venue
Ophthalmology Science
Publisher
Elsevier BV
Published
2024-05
Volume
4
Issue
3
Pages
100420
ISSN
2666-9145 (ISSN-L)
OpenAlex
W4388036714
Cited by
26
References
89
Citations by year
2026: 9 · 2025: 11 · 2024: 6
FWCI
1.33
Type
journal article
Language
en
Open access
Locations
  • Ophthalmology Science (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Amsterdam UMC (VU Amsterdam) - Institutional Repository (submittedVersion, other-oa)
Funders
  • Research to Prevent Blindness
  • Juvenile Diabetes Research Foundation United States of America
Topics
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal Imaging and Analysis
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal and Macular Surgery
Keywords
diabetic macular edema, biomarkers, microperimetry, spectral-domain optical coherence tomography, adaptive optics, optical coherence tomography angiography, level of evidence, expert consensus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review